Arkadios Wealth Advisors Charles River Laboratories International, Inc. Transaction History

Arkadios Wealth Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$351.38 - $448.68 $26,353 - $33,651	-75 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$372.64 - $458.3 $45,462 - $55,912	-122 Reduced 61.93%	75 $30,000
Q2 2021 Jul 28, 2021	BUY	$294.17 - $371.65 $2,647 - $3,344	9 Added 4.79%	197 $72,000
Q1 2021 Apr 26, 2021	SELL	$249.67 - $299.48 $998 - $1,197	-4 Reduced 2.08%	188 $54,000
Q4 2020 Feb 09, 2021	BUY	$222.0 - $252.62 $12,432 - $14,146	56 Added 41.18%	192 $47,000
Q3 2020 Nov 10, 2020	SELL	$175.56 - $226.45 $877 - $1,132	-5 Reduced 3.55%	136 $32.7 Million
Q2 2020 Aug 10, 2020	SELL	$118.84 - $189.72 $3,327 - $5,312	-28 Reduced 16.57%	141 $26.4 Million
Q1 2020 May 14, 2020	SELL	$98.9 - $178.34 $2,868 - $5,171	-29 Reduced 14.65%	169 $21.3 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $24,957 - $30,246	198 New	198 $30,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.